Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - metabolic+syndrome
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Treatment for
Metabolic Syndrome
and Obesity Related Diseases
Background Abdominal obesity is the most commonly observed component of
metabolic syndrome
and a major risk factor for type II diabetes and cardiovascular disease. In addition to obesity, an individual’s risk of cardiovascular disease and type II diabetes is strongly correlated to a series of risk factors, collectively referred to as metabolic...
Published: 7/22/2026
|
Updated: 12/15/2021
|
Inventor(s):
Jan Stevens
,
Paul Blakemore
,
Ines Paraiso
,
Luce Mattio
Keywords(s):
chemical synthesis
,
medicinal
,
metabolic syndrome
,
obesity
,
pharmaceuticals
,
type 2 diabetes
Category(s):
Therapeutics
Immune CB1 Activation for Obesity Therapy
Reference #: 01478 The University of South Carolina is offering licensing opportunities for Immune CB1 activation for obesity therapy Background: The endocannabinoid system regulates various physiological processes such as inflammation and metabolism, and is comprised of cannabinoid receptors, CB1 and CB2, as well as their ligands called endocannabinoids....
Published: 6/11/2026
|
Updated: 5/7/2021
|
Inventor(s):
Prakash Nagarkatti
,
Mitzi Nagarkatti
,
Kathryn Miranda
Keywords(s):
anti-inflammatory pharma
,
cannabinoids
,
CB1
,
inflammation
,
metabolic syndrome
,
Obesity
,
weight loss
Category(s):
Health Sciences
,
Biomedical and Life Sciences